Overview
Tsumura & Co. is a Japan-based company primarily engaged in the pharmaceutical industry. The company specializes in the production and sale of Kampo medicine, a traditional Japanese herbal medicine system, and is a pioneer in its field. Key projects of Tsumura & Co. include the development of new Kampo products, research into the efficacy and safety of Kampo medicine, and the promotion of its use in modern healthcare. Tsumura & Co. also actively contributes to the preservation and sustainable use of medicinal plant resources, demonstrating a commitment to both healthcare and environmental sustainability.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Tsumura & Co. as of June 30, 2025 is 180,497.00 MM.
- The operating income for Tsumura & Co. as of June 30, 2025 is 37,271.00 MM.
- The net income for Tsumura & Co. as of June 30, 2025 is 25,615.00 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 180,497.00 | 37,271.00 | 25,615.00 |
2025-03-31 | 181,093.00 | 40,126.00 | 32,428.00 |
2024-12-31 | 171,792.00 | 33,255.00 | 27,123.00 |
2024-09-30 | 164,614.00 | 30,882.00 | 25,204.00 |
2024-06-30 | 157,499.00 | 25,907.00 | 23,555.00 |
2024-03-31 | 150,845.00 | 20,018.00 | 16,707.00 |
2023-12-31 | 148,793.00 | 22,337.00 | 16,758.00 |
2023-09-30 | 145,238.00 | 19,450.00 | 13,598.00 |
2023-06-30 | 142,662.00 | 19,248.00 | 14,182.00 |
2023-03-31 | 140,043.00 | 20,916.00 | 16,482.00 |
2022-12-31 | 138,240.00 | 21,269.00 | 19,322.00 |
2022-09-30 | 136,237.00 | 22,371.00 | 20,760.00 |
2022-06-30 | 132,192.00 | 22,579.00 | 20,079.00 |
2022-03-31 | 129,546.00 | 22,377.00 | 18,836.00 |
2021-12-31 | 129,783.00 | 20,654.00 | 17,365.00 |
2021-09-30 | 130,305.00 | 19,942.00 | 17,214.00 |
2021-06-30 | 130,886.00 | 19,802.00 | 16,676.00 |
2021-03-31 | 130,883.00 | 19,384.00 | 15,332.00 |
2020-12-31 | 127,545.00 | 20,286.00 | 15,431.00 |
2020-09-30 | 126,440.00 | 20,226.00 | 14,811.00 |
2020-06-30 | |||
2020-03-31 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 357.20 | 357.20 |
2024-09-30 | 331.92 | 331.92 |
2024-06-30 | 310.17 | 310.17 |
2024-03-31 | 219.82 | |
2023-12-31 | 220.16 | 220.16 |
2023-09-30 | 178.38 | 178.38 |
2023-06-30 | 185.74 | 185.74 |
2023-03-31 | 215.63 | |
2022-12-31 | 252.69 | 252.69 |
2022-09-30 | 271.40 | 271.40 |
2022-06-30 | 262.45 | 262.45 |
2022-03-31 | 246.20 | |
2021-12-31 | 226.97 | 226.97 |
2021-09-30 | 225.00 | 225.00 |
2021-06-30 | 217.96 | 217.96 |
2021-03-31 | 200.40 | |
2020-12-31 | 201.69 | 201.69 |
2020-09-30 | 193.59 | 193.59 |
2020-06-30 | 181.79 | 181.79 |
2020-03-31 | 179.96 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Tsumura & Co. as of June 30, 2025 is 34,032.00 MM.
- The cash from investing activities for Tsumura & Co. as of June 30, 2025 is -27,464.00 MM.
- The cash from financing activities for Tsumura & Co. as of June 30, 2025 is 1,153.00 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 34,032.00 | -27,464.00 | 1,153.00 |
2025-03-31 | 33,823.00 | -24,974.00 | -19,871.00 |
2024-12-31 | 28,878.00 | -18,653.00 | -8,539.00 |
2024-09-30 | 22,107.00 | -13,051.00 | -15,045.00 |
2024-06-30 | 4,383.00 | -15,012.00 | -6,620.00 |
2024-03-31 | 5,608.00 | -19,351.00 | -4,417.00 |
2023-12-31 | 6,724.00 | -15,441.00 | -4,421.00 |
2023-09-30 | 7,365.00 | -21,506.00 | -4,263.00 |
2023-06-30 | 11,515.00 | -16,254.00 | 25,262.00 |
2023-03-31 | 16,452.00 | -15,493.00 | 24,423.00 |
2022-12-31 | 12,429.00 | -14,026.00 | 21,467.00 |
2022-09-30 | 19,187.00 | -13,578.00 | 21,544.00 |
2022-06-30 | 22,739.00 | -10,155.00 | -8,228.00 |
2022-03-31 | 21,314.00 | -9,111.00 | -8,181.00 |
2021-12-31 | 21,242.00 | -9,887.00 | -5,909.00 |
2021-09-30 | 17,263.00 | -8,413.00 | -5,952.00 |
2021-06-30 | 14,016.00 | -11,667.00 | -10,986.00 |
2021-03-31 | 16,102.00 | -7,352.00 | -10,425.00 |
2020-12-31 | 20,232.00 | -22,865.00 | 2,388.00 |
2020-09-30 | 20,149.00 | -30,766.00 | 2,434.00 |
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Management Effectiveness
- The roa for Tsumura & Co. as of June 30, 2025 is 0.07.
- The roe for Tsumura & Co. as of June 30, 2025 is 0.11.
- The roic for Tsumura & Co. as of June 30, 2025 is 0.08.
- The croic for Tsumura & Co. as of June 30, 2025 is -0.01.
- The ocroic for Tsumura & Co. as of June 30, 2025 is 0.08.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | 0.07 | 0.11 | 0.08 | -0.01 | 0.08 |
2025-03-31 | 0.06 | 0.09 | 0.07 | 0.01 | 0.07 |
2024-12-31 | 0.06 | 0.08 | 0.06 | 0.00 | 0.06 |
2024-09-30 | 0.06 | 0.08 | 0.06 | -0.04 | 0.01 |
2024-06-30 | 0.06 | ||||
2024-03-31 | 0.06 | ||||
2023-12-31 | 0.05 | -0.07 | |||
2023-09-30 | 0.05 | 0.07 | |||
2023-06-30 | 0.05 | ||||
2023-03-31 | 0.06 | ||||
2022-12-31 | |||||
2022-09-30 | 0.00 | ||||
2022-06-30 | 0.00 | 0.00 | |||
2022-03-31 | 0.00 | ||||
2021-12-31 | 0.00 | ||||
2021-09-30 | 0.06 | 0.08 | |||
2021-06-30 | 0.05 | 0.06 | -0.02 | 0.05 | |
2021-03-31 | 0.05 | 0.07 | 0.05 | 0.01 | 0.06 |
2020-12-31 | 0.05 | 0.07 | 0.05 | 0.01 | 0.07 |
2020-09-30 | 0.05 | 0.07 | 0.05 | -0.02 | 0.07 |
2020-06-30 | 0.05 | 0.07 | 0.05 | -0.00 | 0.07 |
2020-03-31 | 0.05 | 0.07 | 0.05 | 0.01 | 0.07 |
Gross Margins
- The gross margin for Tsumura & Co. as of June 30, 2025 is 0.50.
- The net margin for Tsumura & Co. as of June 30, 2025 is 0.18.
- The operating margin for Tsumura & Co. as of June 30, 2025 is 0.22.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.50 | 0.18 | 0.22 |
2025-03-31 | 0.49 | 0.16 | 0.19 |
2024-12-31 | 0.49 | 0.15 | 0.19 |
2024-09-30 | 0.48 | 0.15 | 0.16 |
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | 0.10 | 0.13 | |
2023-06-30 | 0.10 | 0.13 | |
2023-03-31 | 0.12 | 0.15 | |
2022-12-31 | |||
2022-09-30 | 0.00 | 0.00 | |
2022-06-30 | 0.00 | 0.00 | |
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | 0.57 | 0.12 | 0.15 |
2021-03-31 | 0.52 | 0.13 | 0.17 |
2020-12-31 | 0.59 | 0.12 | 0.16 |
2020-09-30 | 0.59 | 0.12 | 0.16 |
2020-06-30 | 0.58 | 0.11 | 0.16 |
2020-03-31 | 0.59 | 0.11 | 0.15 |
Identifiers and Descriptors
Central Index Key (CIK) |
Industry Groups
SIC 2833 - Medicinal Chemicals and Botanical Products |